Small
Normal
Large
2012.01.19
PDF/98KB
Announcement of basic agreement concerning co-promotion of anti-depressant Paxil® CR Tablets
2012.01.05
"Corporate profile" An English version and a Japanese version are updated.
2011.12.06
Posted Factbook 2011 ver.2
2011.12.05
PDF/153KB
STEDESA™ clinical data presented at 2011 American Epilepsy Society Annual Meeting
2011.12.01
PDF/25KB
Dainippon Sumitomo Pharma and Yoshitomiyakuhin terminate co-promotion of antipsychotics, LONASEN and LULLAN
2011.11.30
PDF/43KB
Dainippon Sumitomo Pharma announces application for manufacturing and marketing approval for “DSP-8153”, combination product of irbesartan and amlodipine besilate
A Message from the President
Corporate Philosophy
Corporate Governance
Compliance
Risk Management
Corporate History
Corporate Profile
Business Units
Pharmaceutical Business
Other Products
Board of Directors and Executive Officers
Organizational Chart